Sunday, June 12, 2022 2:59:56 PM
6/11/22, 06:54 PM
- Yup an we are about to enter into clinical trials on that Check Point Inhibitor NR2F6 any day. It could happen on Monday! Matter if it's this week or next, one way or another, it's going to happen soon! When that happens there will be an immediate fundamental shift in the valuation of this company that will push the pps upward. The fact that Dr. Koos has submitted the IND for NR2F6 to develop an mRNA vaccine for treating pancreatic and colon cancer, means he must have completed Pre-Clinical for that to happen for reason the results of Pre-Clinical are looked at closely before granting approval to proceed to Phase
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM